Renal Artery Disease

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

Conditions:   Chronic Kidney Disease (CKD);   Type 2 Diabetes Mellitus (T2DM);   Coronary Artery Disease (CAD)
Interventions:   Drug: Clopidogrel;   Drug: Clopidogrel active metabolite
Sponsor:   University of Florida
Not yet recruiting

CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?

Conditions:   Stable Angina;   Acute Kidney Injury;   Contrast-induced Nephropathy
Intervention:   Procedure: Iodinated contrast media
Sponsor:   I.M. Sechenov First Moscow State Medical University
Completed

The Future of Revascularization Using a Bioprotec Graft

Condition:   Peripheral Artery Disease
Intervention:   Procedure: Revascularization using a BIOPROTEC Graft
Sponsor:   Centre Hospitalier René Dubos
Recruiting

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Condition:   Prevention & Control
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
Sponsors:   Bayer;   Population Health Research Institute;   Janssen Research & Development, LLC
Active, not recruiting

Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure

Conditions:   Severe Obesity;   Renal Failure
Interventions:   Procedure: Gastric Bypass;   Other: Weight Loss Program
Sponsor:   Vanderbilt University
Recruiting

Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in Volunteers

Condition:   Cardiovascular Disease
Intervention:   Drug: [14C]AZD5718 Oral Suspension
Sponsors:   AstraZeneca;   Quotient Sciences
Completed

The PRE-OP ENERGY Trial

Conditions:   Cardiac Valve Disease;   Coronary Artery Disease;   Organ Failure, Multiple
Intervention:   Dietary Supplement: High energy diet
Sponsor:   University of Leicester
Recruiting

Quantitative Measurement of Myocardial Perfusion by Cardiac CT in Patients

Conditions:   Coronary Disease;   Aortic Valve Stenosis
Intervention:  
Sponsors:   Bakulev Scientific Center of Cardiovascular Surgery;   Medical University of Graz;   Graz University of Technology
Enrolling by invitation

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease;   Cardiovascular Diseases
Interventions:   Drug: RVX000222;   Drug: Placebo (for RVX000222);   Drug: atorvastatin;   Drug: rosuvastatin
Sponsors:   Resverlogix Corp;   PPD;   ICON plc;   Medidata Solutions
Active, not recruiting

Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion

Condition:   Coronary Artery Disease
Intervention:   Biological: Evolocumab
Sponsors:   ECRI bv;   Amgen;   GE Healthcare;   HeartFlow, Inc.
Not yet recruiting

The Role of Endothelial Dysfunction in Adult Polycystic Kidney Disease

Condition:   Polycystic Kidney, Autosomal Dominant
Intervention:   Diagnostic Test: Peripheral (digital) arterial tonometry
Sponsors:   Sheffield Teaching Hospitals NHS Foundation Trust;   University of Sheffield
Completed

Intraoperative Hypotension and Acute Kidney Injury After Off-pump Coronary Artery Bypass Grafting Surgery

Conditions:   Coronary Artery Bypass, Off-Pump;   Intraoperative Hypotension;   Acute Kidney Injury
Intervention:  
Sponsor:   Peking University First Hospital
Completed

Safety of Fusion Guidance During Peripheral Revascularisation

Condition:   Arteriopathy
Interventions:   Procedure: fusion imaging guidance technology;   Procedure: 2D X-ray screen
Sponsor:   Nantes University Hospital
Recruiting

A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

Condition:   Chronic Kidney Disease
Interventions:   Drug: PRT-201;   Drug: Placebo
Sponsor:   Proteon Therapeutics
Completed

Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease

Conditions:   Regional Anesthesia Morbidity;   Local Anesthetic Drug Adverse Reaction
Intervention:   Procedure: Sciatic nerve block
Sponsor:   Seoul National University Hospital
Not yet recruiting

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

Condition:   Acute Kidney Injury (AKI)
Interventions:   Drug: ASP1128;   Drug: Placebo
Sponsor:   Astellas Pharma Inc
Not yet recruiting

The PATHFINDER Study: A Feasibility Trial

Conditions:   Coronary Artery Disease;   Delirium
Interventions:   Drug: Ropivacaine;   Drug: Ketamine;   Drug: Remifentanil;   Drug: Dexmedetomidine;   Drug: Rocuronium;   Drug: Propofol;   Drug: Sevoflurane;   Device: EEG monitoring
Sponsor:   Beth Israel Deaconess Medical Center
Not yet recruiting

Xanthine Oxidase Inhibition in Renal Transplant Recipients

Condition:   Complications of Renal Transplant
Intervention:   Drug: allopurinol or placebo
Sponsor:   Roberto S Kalil
Completed

The International Survey of Acute Coronary Syndromes-ARCHIVES

Conditions:   Acute Coronary Syndrome;   Unstable Angina Pectoris;   Myocardial Infarction;   Coronary Disease
Intervention:   Other: Non-interventional patient registry
Sponsor:   University of Bologna
Recruiting

Effects of Aerobic Exercise on Arteriovenous Fistula

Condition:   Chronic Kidney Diseases
Interventions:   Other: Exercise group;   Other: Control group
Sponsor:   Hospital de Clinicas de Porto Alegre
Recruiting

The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.

Conditions:   Coronary Heart Disease;   Anemia;   Bronchial Asthma;   Stroke;   Epilepsy;   Parkinson's Disease;   Heart Rhythm Disorders;   Alzheimer's Disease;   Neuromuscular Diseases;   Diabetes;   Chronic Heart Failure;   Chronic Obstructive Pulmonary Disease;   Chronic Kidney Diseases
Intervention:  
Sponsors:   Russian Federation of Anesthesiologists and Reanimatologists;   Kuban State Medical University
Recruiting

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Coronary Artery Disease;   Heart Diseases;   Myocardial Ischemia
Interventions:   Procedure: cardiac catheterization;   Procedure: coronary artery bypass graft surgery;   Procedure: percutaneous coronary intervention;   Behavioral: Lifestyle;   Drug: Medication
Sponsors:   NYU Langone Health;   New York University;   Stanford University;   National Heart, Lung, and Blood Institute (NHLBI);   Albany Stratton VA Medical Center;   Cedars-Sinai Medical Center;   Columbia University;   Duke University;   East Carolina University;   Emory University;   Harvard University;   Massachusetts General Hospital;   Montreal Heart Institute;   University of British Columbia;   University of Missouri, Kansas City;   Vanderbilt University
Active, not recruiting

Hepatitis C Treatment and Atherosclerosis

Conditions:   Chronic Hepatitis C;   Atherosclerosis
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study

Conditions:   Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions:   Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
Sponsor:   Medtronic Vascular
Recruiting

SPYRAL HTN-ON MED Study

Conditions:   Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions:   Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
Sponsor:   Medtronic Vascular
Recruiting

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa

Condition:   Anemia in Chronic Kidney Disease in Non-dialysis Patients
Interventions:   Drug: Roxadustat;   Drug: darbepoetin alfa
Sponsors:   Astellas Pharma Europe B.V.;   FibroGen
Active, not recruiting

Insulin Resistance and Atherosclerosis in Women With Lupus

Conditions:   Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Intervention:  
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

Conditions:   Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed